论文摘要:
Trauma is the leading cause of
death in persons between the ages of 1 and 44. The preponderance of trauma
victims are young males; their mortality rate after trauma is not only higher
compared to females but they are also more susceptible to subsequent sepsis.
Our studies show that after the induction of sepsis in animals, even if the animals
had undergone soft-tissue trauma-hemorrhage (T-H) and resuscitation first, the
survival rate in proestrus (PE) females was significantly higher than in
age-matched males. Ovariectomized (OVX) females, however, were extremely
susceptible to sepsis after T-H as compared to PE females. Our clinical
epidemiological studies also show the premenopausal females tolerate trauma
better than age matched males. Thus, the prevailing hormonal milieu at the time
of injury dictates whether the host is going to be susceptible to sepsis and
mortality or tolerant to sepsis and mortality after trauma.
Administration of 17β-estradiol (E2)
after major blood loss (60% of the circulating blood volume), maintained the rats
in a state of permissive hypotension for 6 hr with no additional fluid
administration. Survival in the E2-treated animals was significantly higher
than in vehicle-treated animals. To examine if
ethinyl estradiol-3-SO4 (EE-3-SO4) was also protective,
rats were given a
single dose of 1 mg/kg EE-3-SO4 in 0.4 ml/kg of saline following
controlled 60% hemorrhage. The survival rates in EE-3-SO4-treated
rats increased 6-fold even in the absence of resuscitation. Administration of a single dose
of 1 mg/kg EE-3-SO4 in 1 ml/kg of saline following severe hemorrhage
also increased survival in 60% acutely-bled minipigs by 3.5-fold
In a lateral fluid percussion injury model
of traumatic brain injury (TBI), E2 administration one hr. after TBI, markedly decreased
edema formation and ICP at 24 hr after TBI. Brain metabolism (using
fludoexoyglucose-PET/CT and diffusion tension imaging analysis) indicated that
the relative % standard uptake values in E2-treated rats were significantly
higher than in the vehicle-treated animals. To examine if EE-3-SO4 was also
protective following TBI, rats were given EE-3-SO4 or vehicle 1 hr
post-TBI. Animal activity was reduced after TBI more so that the EEs treated
animals. The weight loss 3 days post-TBI was significantly less in the
EE-treated group than in the vehicle-treated group.
This hormone
(i.e., estrogens) should
therefore be considered as a novel adjunct for preserving life when fluid
resuscitation is not possible for an extended period of time after major blood
loss. Furthermore, EE-3-SO4 promotes
recovery by increasing brain metabolism, resolving edema and improving
physiologic parameters if administered 1 hr post-TBI. EE-3-SO4 administration
post-TBI improves physical activity, and decreases weight loss in animals. Estrogen therefore appears to
be neuroprotective even after TBI. These results, together with similar findings in post-hemorrhage
minipigs, support the use of EE-3-SO4 for: 1) severe hemorrhage when
standard resuscitation is not available or feasible, and 2) conditions in which prolonged transportation periods are
required for definitive treatment of the injured. Thus, evaluation
of the safety/efficacy of EE-3-SO4 in humans encountering severe
trauma is desirable.